Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - MedicX Fund Limited

1 Mar 2019 13:10

RNS Number : 6276R
Royal Bank of Scotland Group PLC
01 March 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Royal Bank of Scotland Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Adam & Company Investment Management Limited

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MedicX Fund Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

28 February 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,554,153

 

1.48

0

0.00

(2) Cash-settled derivatives:

 

0

0

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0.00

 

TOTAL:

6,554,153

 

1.48

0

0.00

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary

Sale

 

3,500

£0.926

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

 

 

Date of disclosure:

01 March 2019

Contact name:

Suzanne Davidson

Telephone number*:

0131 626 4120

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

LEI: 2138005O9XJIJN4JPN90

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETUGUUUWUPBGWG
Date   Source Headline
1st Jul 20157:00 amRNSTotal voting rights
1st Jul 20157:00 amRNSAllotment of scrip shares to Directors
26th Jun 20157:00 amRNSAcquisition - primary healthcare centre in Ireland
15th Jun 20154:34 pmRNSDirector Declaration
11th Jun 20157:00 amRNSScrip Dividend Declaration
5th Jun 20157:00 amRNSAcquisition of new primary healthcare centre
3rd Jun 201512:46 pmRNSNotification of Major Interest in Shares
22nd May 201512:16 pmRNSScrip Calculation Price for the June 2015 Dividend
22nd May 20157:00 amRNSResults for the six month ended 31 March 2015
19th May 20151:50 pmRNSPublication of Circular Scrip Div Scheme
1st May 20154:40 pmRNS£50 million private placement of loan notes
27th Apr 20159:53 amRNSNotice of dividend
1st Apr 201510:20 amRNSAllotment of scrip shares to Directors
1st Apr 201510:20 amRNSAllotment of scrip shares to Investment Adviser
1st Apr 201510:20 amRNSTotal voting rights
24th Mar 20154:59 pmRNSSale of ordinary shares out of treasury
12th Mar 201511:44 amRNSScrip Dividend Declaration
2nd Mar 20155:25 pmRNSNotification of major interest in shares
24th Feb 20152:45 pmRNSSale of ordinary shares out of treasury
20th Feb 20154:19 pmRNSTransaction in Own Shares
19th Feb 201511:30 amRNSScrip Calculation Price for March 2015 Dividend
18th Feb 201510:25 amRNSIssue of Equity
17th Feb 20152:13 pmRNSPublication of Circular Scrip Div Scheme
17th Feb 201512:18 pmRNSAnnual General Meeting results
12th Feb 201510:52 amRNSQuarterly Net Asset Value ("NAV") announcement
12th Feb 201510:48 amRNSAcquisition of a new primary healthcare centre
5th Feb 20154:35 pmRNSSale of ordinary shares out of treasury
29th Jan 20153:36 pmRNSSale of ordinary shares out of treasury
27th Jan 20154:09 pmRNSSale of ordinary shares out of treasury
27th Jan 20157:01 amRNSNotice of dividend
27th Jan 20157:00 amRNSPosting of Annual Report
23rd Jan 20155:30 pmRNSAnnual General Meeting
8th Jan 201512:44 pmRNSAcquisition of a new primary healthcare centre
2nd Jan 20157:01 amRNSTotal voting rights
2nd Jan 20157:00 amRNSAllotment of scrip shares to Company Directors
2nd Jan 20157:00 amRNSAllotment of scrip shares to Investment Adviser
17th Dec 20142:53 pmRNSNotification of major interest in shares
16th Dec 20144:25 pmRNSAcquisition of two new primary healthcare centres
16th Dec 20147:00 amRNS£50 million private placement of loan notes
12th Dec 201412:13 pmRNSNotification of major interest in shares
10th Dec 20144:32 pmRNSConfirmation of Board Changes
10th Dec 20144:28 pmRNSScrip Dividend Declaration
10th Dec 20144:26 pmRNSOrdinary Shares out of Treasury
10th Dec 20147:00 amRNSResults for the year ended 30 September 2014
20th Nov 20143:18 pmRNSScrip Calculation Price for December Dividend
19th Nov 20142:28 pmRNSNotification in accordance - Listing Rule 9.6.13
18th Nov 20145:30 pmRNSNotification of Major Interest in Shares
17th Nov 20149:12 amRNSBoard Changes
31st Oct 20142:44 pmRNSInvestment Adviser Name Change
27th Oct 201410:47 amRNSNotice of Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.